Press release
Autoimmune Disease Therapeutics Market on target to hit $153.2 billion by 2025: North America expected to remain dominant throughout the forecast period
Autoimmune Disease Therapeutics Market
Anti-autoimmune disease drugs include anti-inflammatory drugs, antihyperglycemics, NSAIDs, interferons, immunosuppressants, corticosteroids, beta blockers and other types of drugs. Demand for autoimmune disease drugs is projected to increase during the forecast period due to the spread of autoimmune diseases, advances in screening and diagnostic procedures, and the broad availability of advanced therapeutics. Furthermore, the presence of pipeline drugs such as tocilizumab, barricinib, certolizumab, secukinumab, etanercept, olokizumab, abatacept, apremilast, PF-06438179, golimumab, ustekinumab, etrolizumab and tofacitinib is expected to further promote market growth.
Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/5185
Depending on the drug type, the global autoimmune disease therapeutic market is classified as anti-inflammatory, antihyperglycemic, NSAID, interferon and others. Anti-inflammatory drugs were a major contributor to sales in 2017 and are anticipated to maintain dominance over the forecast period due to increased demand for anti-inflammatory drugs and the launch of the latest anti-inflammatory drugs through a supplemental reimbursement policy for the use of advanced anti-inflammatory drugs. The release of pipeline anti-inflammatory drugs such as tocilizumab, certolizumab, secukinumab, etanercept, golimumab and others is expected to affect market growth.
Depending on the indication, the market is classified as rheumatic disease, type 1 diabetes, multiple sclerosis, inflammatory bowel disease and other signs. Rheumatoid diseases accounted for a large proportion in 2017, and the duration of treatment is expected to be prolonged due to the high prevalence of arthritis, fibromyalgia, systemic lupus erythematosus, gout, scleroderma, and multiple myositis. Rheumatoid diseases, usefulness of advanced therapeutic agents for the treatment of these diseases.
According to the sales channel, the market is divided into hospital pharmacies, pharmacies and retail pharmacies, and online stores. Online services are expected to grow rapidly over the forecast period as online purchasing preference increases and the number of Internet users increases as more people become aware of online pharmacies than traditional methods. On the other hand, the pharmacy and retail pharmacy sectors are estimated to be major revenue contributors due to the large presence of these pharmacies.
Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/5185
Key Findings of the Autoimmune Disease Therapeutics Market:
• Based on indication, the rheumatic disease segment held nearly half of the global market share in 2017, and is projected to grow at a CAGR of 5.2% from 2018 to 2025.
• Based on sales channel, the online stores segment is expected to experience rapid growth and is projected to grow at a CAGR of 6.8% during the forecast period 2018-2025.
• Depending on drug class, the anti-inflammatory segment accounted for nearly half of the global market share in 2017, and is projected to grow at a CAGR of 5.2% from 2018 to 2025.
• Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 6.3% during the forecast period.
North America accounted for a major market share in 2017, and is expected to remain dominant throughout the forecast period. Higher prevalence of autoimmune disease, early diagnosis, easy availability of advanced therapeutics, strong presence of key players, favorable reimbursement in healthcare system, and higher number of trained medical professionals are key drivers of the North America autoimmune disease therapeutics market. On the other side, Asia-Pacific is expected to experience the highest growth rate during the forecast period owing to increase in number of target population, rise in adoption of therapeutics with development in healthcare infrastructure.
Access Full Summery @ https://www.alliedmarketresearch.com/autoimmune-disease-therapeutics-market
About Us:
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Autoimmune Disease Therapeutics Market on target to hit $153.2 billion by 2025: North America expected to remain dominant throughout the forecast period here
News-ID: 1663994 • Views: …
More Releases from Allied Market Research
Endpoint Security Market Size Growing at 8.4% CAGR Reach USD 31.9 Billion by 203 …
Allied Market Research published a new report, titled, "Endpoint Security Market Size Growing at 8.4% CAGR Reach USD 31.9 Billion by 2031." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain a thorough understanding of the industry and determine…
Smart Manufacturing Market Size Growing at 13.7% CAGR Reach USD 860 Billion by 2 …
Allied Market Research published a new report, titled, "Smart Manufacturing Market Size Growing at 13.7% CAGR Reach USD 860 Billion by 2031." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain a thorough understanding of the industry and determine…
Data Virtualization Market Sizze Growing at 21.7% CAGR Reach USD 22.2 Billion by …
According to the report published by Allied Market Research, Data Virtualization Market Sizze Growing at 21.7% CAGR Reach USD 22.2 Billion by 2031. The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers valuable able guidance to leading players, investors, shareholders, and startups in devising strategies for sustainable growth and gaining a competitive edge in the market.
Driving Factors…
Europe IoT Market Growing at 19.0% CAGR Reach USD 12.30 Billion by 2031
According to the report published by Allied Market Research, Europe IoT Market Growing at 19.0% CAGR Reach USD 12.30 Billion by 2031. The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers valuable able guidance to leading players, investors, shareholders, and startups in devising strategies for sustainable growth and gaining a competitive edge in the market.
The Europe IoT…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
